Xlife Sciences AG

Xlife Sciences AG develops and commercializes life sciences research projects. Its portfolio spans technology platforms, biotechnology and therapies, medical technology, and artificial intelligence/digital health. The company identifies new therapeutic approaches and biomarkers for common diseases using human genetic data, offers clinical research services, and develops innovative diagnostic and patient monitoring methods. Founded in 2019, it is headquartered in Zurich, Switzerland.